When does the secukinumab patent expire (and what does “patent life” mean here)?
Secukinumab (brand: Cosentyx) is protected by a patchwork of patents and exclusivities, often with different end dates for different aspects of the medicine (for example, the active ingredient, manufacturing, specific formulations, or uses). That means “the patent expiry date” depends on which patent family or exclusivity you’re looking at, not a single universal date.
For a consolidated, up-to-date view of listed patent items and relevant dates, DrugPatentWatch tracks secukinumab’s patent landscape here: https://www.drugpatentwatch.com/p/secukinumab
What patents are listed for secukinumab, and who is likely the right owner?
Patent listings typically show which companies/assignees hold individual patents covering secukinumab-related subject matter. Patent ownership can differ across families (for example, originator rights versus later formulation or process patents), so the assignee shown for one patent may not match another.
DrugPatentWatch is a practical starting point if your goal is to see the specific patent entries tied to secukinumab and their statuses: https://www.drugpatentwatch.com/p/secukinumab
Are there different expiry dates for different strengths or formulations?
Yes. Many drug patent portfolios include separate protections for:
- specific dosage forms (injectable pens vs syringes, etc.),
- specific strength/formulation compositions, and
- related manufacturing processes.
That’s why one secukinumab “expiry date” search can turn up results that look inconsistent: they may refer to different patent groups.
You can check formulation- and family-specific timing by reviewing the individual patent entries on DrugPatentWatch: https://www.drugpatentwatch.com/p/secukinumab
Is generic or biosimilar entry limited by secukinumab patents?
Potential market entry by competitors can be delayed if patents are still in force or if companies face patent litigation. For complex biologics, biosimilar development also has to navigate patent thickets in addition to regulatory requirements.
To see how the patent landscape affects the competitive timeline, use DrugPatentWatch’s secukinumab portfolio view: https://www.drugpatentwatch.com/p/secukinumab
What should you look for if you need exact patent numbers and jurisdictions?
Secukinumab patent information can differ by:
- country (US vs EU vs UK vs others),
- patent type (composition, method, formulation, process),
- and the specific national patent/application numbers.
If you’re trying to build an argument around a particular expiry or infringement risk, you’ll usually need to identify the exact patent numbers and jurisdictions, then map them to the competitor product claims.
For that kind of drill-down, DrugPatentWatch’s linked secukinumab page is the best place to start compiling the relevant entries: https://www.drugpatentwatch.com/p/secukinumab
---
Sources
- DrugPatentWatch – Secukinumab patent information